STRO - ストゥロ・バイオファ―マ （Sutro Biopharma Inc.） ストゥロ・バイオファ―マSTROのチャート
STROの企業情報
| symbol | STRO |
|---|---|
| 会社名 | Sutro Biopharma Inc （ストゥロ・バイオファ―マ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 Sutro Biopharma Inc. is a clinical stage drug discovery development and manufacturing company. The Company is focused on using its integrated cell-free protein synthesis platform XpressCF to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities including cytokine-based immuno-oncology (I/O) therapeutics antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidate includes STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against folate receptor-alpha (FolRa) for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its XpressCF Platform. ストゥロ・バイオファ―マは米国のバイオ医薬品企業。独自プラットフォ―ムであるXpressCFを介し、がん及び自己免疫疾患のためのタンパク質治療薬の新規開発・製造に焦点をあて事業を行う。主な製品候補には、多発性骨髄腫及び非ホジキンリンパ腫の治療薬STRO-001やSTRO-002のほか、卵巣がん及び子宮内膜がんの治療薬BCMA ADCがある。 Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics. |
| 本社所在地 | 310 Utah Avenue Suite 150 South San Francisco CA 84080 USA |
| 代表者氏名 | William J. Newell ウィリアム・J.・ニューエル |
| 代表者役職名 | CEO Director |
| 電話番号 | +1 650-392-8412 |
| 設立年月日 | 37712 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | － |
| url | www.sutrobio.com |
| nasdaq_url | https://www.nasdaq.com/symbol/stro |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -35.34900 |
| 終値（lastsale） | 14.6 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額（百万ドル） 319.72020 |
| 売上高 | 売上高（百万ドル） 33.03600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 445.62320 |
| 当期純利益 | 当期純利益（百万ドル） -40.34900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Sutro Biopharma Inc revenues decreased 62% to $11.5M. Net loss increased from $2.9M to $23.6M. Revenues reflect Collaboration revenue decrease of 77% to $7M. Higher net loss reflects General and administrative increase of 16% to $8.1M (expense) Research and development increase of 4% to $26.7M (expense) Interest Expense increase from $0K to $784K (expense). |
STROのテクニカル分析
STROのニュース
Can you now get a good deal on Sutro Biopharma Inc.’s shares? 2023/01/04 14:48:00 US Post News
In Tuesday’s session, Sutro Biopharma Inc. (NASDAQ:STRO) marked $8.02 per share, down from $8.08 in the previous session. While Sutro Biopharma Inc. has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -46.10%, with highs and lows ranging from $15.67 to […]
Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? 2022/12/24 17:00:00 Stocks Register
Sutro Biopharma Inc. (NASDAQ:STRO) price on Friday, December 23, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.87. A look at the stock’s price movement, the close in the last trading session was $7.03, moving within a range at $6.665 and $7.13. The beta value … Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? Read More »
How should investors view Sutro Biopharma Inc. (STRO)? 2022/12/07 16:16:00 US Post News
As of Tuesday, Sutro Biopharma Inc.’s (NASDAQ:STRO) stock closed at $7.41, up from $7.39 the previous day. While Sutro Biopharma Inc. has overperformed by 0.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -52.35%, with highs and lows ranging from $16.60 to $3.33, […]
Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? 2022/12/03 14:00:00 Marketing Sentinel
Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $7.10, to imply a decrease of -4.31% or -$0.32 in intraday trading. The STRO share’s 52-week high remains $16.60, putting it -133.8% down since that … Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? Read More »
Sutro Biopharma (STRO) Investor Presentation - Slideshow (NASDAQ:STRO) 2022/12/02 14:14:28 Seeking Alpha
The following slide deck was published by Sutro Biopharma, Inc.
Can you now get a good deal on Sutro Biopharma Inc.’s shares? 2023/01/04 14:48:00 US Post News
In Tuesday’s session, Sutro Biopharma Inc. (NASDAQ:STRO) marked $8.02 per share, down from $8.08 in the previous session. While Sutro Biopharma Inc. has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -46.10%, with highs and lows ranging from $15.67 to […]
Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? 2022/12/24 17:00:00 Stocks Register
Sutro Biopharma Inc. (NASDAQ:STRO) price on Friday, December 23, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.87. A look at the stock’s price movement, the close in the last trading session was $7.03, moving within a range at $6.665 and $7.13. The beta value … Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? Read More »
How should investors view Sutro Biopharma Inc. (STRO)? 2022/12/07 16:16:00 US Post News
As of Tuesday, Sutro Biopharma Inc.’s (NASDAQ:STRO) stock closed at $7.41, up from $7.39 the previous day. While Sutro Biopharma Inc. has overperformed by 0.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -52.35%, with highs and lows ranging from $16.60 to $3.33, […]
Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? 2022/12/03 14:00:00 Marketing Sentinel
Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $7.10, to imply a decrease of -4.31% or -$0.32 in intraday trading. The STRO share’s 52-week high remains $16.60, putting it -133.8% down since that … Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? Read More »
Sutro Biopharma (STRO) Investor Presentation - Slideshow (NASDAQ:STRO) 2022/12/02 14:14:28 Seeking Alpha
The following slide deck was published by Sutro Biopharma, Inc.
Can you now get a good deal on Sutro Biopharma Inc.’s shares? 2023/01/04 14:48:00 US Post News
In Tuesday’s session, Sutro Biopharma Inc. (NASDAQ:STRO) marked $8.02 per share, down from $8.08 in the previous session. While Sutro Biopharma Inc. has underperformed by -0.74%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -46.10%, with highs and lows ranging from $15.67 to […]
Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? 2022/12/24 17:00:00 Stocks Register
Sutro Biopharma Inc. (NASDAQ:STRO) price on Friday, December 23, fall -2.28% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $6.87. A look at the stock’s price movement, the close in the last trading session was $7.03, moving within a range at $6.665 and $7.13. The beta value … Is Sutro Biopharma Inc. (NASDAQ: STRO) A Suitable Stock For New Investors Now? Read More »
How should investors view Sutro Biopharma Inc. (STRO)? 2022/12/07 16:16:00 US Post News
As of Tuesday, Sutro Biopharma Inc.’s (NASDAQ:STRO) stock closed at $7.41, up from $7.39 the previous day. While Sutro Biopharma Inc. has overperformed by 0.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STRO fell by -52.35%, with highs and lows ranging from $16.60 to $3.33, […]
Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? 2022/12/03 14:00:00 Marketing Sentinel
Sutro Biopharma Inc. (NASDAQ:STRO)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.01. At the close of trading, the stock’s price was $7.10, to imply a decrease of -4.31% or -$0.32 in intraday trading. The STRO share’s 52-week high remains $16.60, putting it -133.8% down since that … Should You Expect Sutro Biopharma Inc. (NASDAQ:STRO) To Recover From Its 53.1% Gain From Highs? Read More »